MORRISTOWN, NJ – The Leukemia and Lymphoma Society’s New Jersey chapter appointed Charles Farber, M.D., Ph.D., to its Board of Directors to serve a four-year term. Dr. Farber is chair, Hematologic Malignancy Panel, at Carol G. Simon Cancer Center, Morristown Medical Center and a member of Regional Cancer Care Associates.
Dr. Farber began his involvement with The Leukemia & Lymphoma Society (LLS) in 2009 when he was honored at the annual LLS golf outing. He was recommended by a board member who became one of his patients when diagnosed with acute lymphoblastic leukemia, and because of his outstanding work for blood cancer patients.
Since then he has been very involved in other LLS events including serving on the Executive Leadership Committee for the Light The Night Walks.
Stacey Boman Weathers, executive director of the New Jersey chapter, said that Dr. Farber has helped open many doors for LLS in the medical community and encouraged new partnerships with major hospitals in the area.
“Dr. Farber has a very impressive list of credentials and is a leader in the fields of hematology and oncology. We are honored to welcome him to our Board of Directors as we know he will continue to support our work and inspire others to help us find cures and ensure access to treatments for blood cancer patients,” Weathers said. Dr. Farber attended the University of Rochester where he received his Bachelor’s degree in Chemistry with High Distinction and Magna Cum Laude. He attended New York University where he received dual M.D. and Ph.D. doctorates studying white blood cell biology. He completed his internship and residency in Internal Medicine followed by a fellowship in Hematology and Oncology at New York Hospital/Cornell University Medical Center.
After completing training, Dr. Farber joined the faculty of Memorial Sloan-Kettering Cancer Center on the Lymphoma Service. He is currently a Clinical Assistant Professor of Medicine at Rutgers Medical School. Dr. Farber has published 60 scientific papers in the areas of leukemia, lymphoma, white blood cell disorders and hematopoietic growth factors. He serves as a reviewer for several medical publications, is an investigator in numerous clinical trials for patients with hematologic malignancies and serves on several national scientific advisory boards studying blood disorders. Dr. Farber’s board certifications include: Diplomat, American Board of Internal Medicine; Diplomat, American Board of Internal Medicine: Medical Oncology; and Diplomat, American Board of Internal Medicine: Hematology. He is a member of the American Society of Clinical Oncology and American Society of Hematology.
About The Leukemia & Lymphoma Society
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org
. Patients should contact the Information Resource Center at (800) 955-4572
, Monday through Friday, 9 a.m. to 9 p.m. ET
About Regional Cancer Care Associates
Regional Cancer Care Associates (RCCA), one of the largest oncology physician networks in the US, is transforming oncology care by ensuring patients and their caregivers are an active part of the treatment team in all aspects of the management of their disease in a way that is life-enriching and respectful.
Regional Cancer Care Associates extends across New Jersey with more than 100 cancer care specialists and is supported by 700 employees at 25 care delivery sites, providing care to more than 23,000 new patients annually and over 245,000 existing patients. RCCA takes responsibility to ensure access to the highest quality, compassionate and cutting-edge cancer care for its patients while controlling the cost of this care. For more information visit: www.regionalcancercare.org
About Morristown Medical Center
Morristown Medical Center, located in Morristown, NJ, is part of Atlantic Health System, one of the largest non-profit health care systems in New Jersey. Accredited by The Joint Commission, the hospital was recognized by U.S. News & World Report as a top hospital nationwide for cardiology, heart surgery, gynecology and geriatrics. Morristown Medical Center also ranked as a “Best Regional Hospital” for cancer, diabetes & endocrinology, neurology and neurosurgery, orthopedics as well as gastroenterology & GI Surgery, nephrology, pulmonology and urology. Morristown Medical Center’s Gagnon Cardiovascular Institute performs more cardiac surgeries than any other hospital in New Jersey, placing its cardiac program in the top two percent in the country. Morristown Medical Center is verified as a Level I Regional Trauma Center by the American College of Surgeons and designated a Level II by the state of New Jersey and was re-designated a Magnet Hospital for Excellence in Nursing Service, the highest level of recognition by American Nurses Credentialing Center for facilities that provide acute care services, a distinction awarded to less than five percent of U.S. hospitals. For more information, please visit AtlanticHealth.org/Morristown